文献速递口腔修复与种植口腔颌面外科

超多孔二氧化钛支架作为植骨替代材料用于人牙槽嵴保存的临床表现——可行性研究

Clinical Performance of Ultra-Porous TiO2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation-A Feasibility Study.
PubMed 文献 · Clin Oral Implants Res · 2025-11-30

本研究纳入9名需拔除前磨牙或磨牙的受试者,在拔牙窝内放置多孔陶瓷二氧化钛支架并覆盖可吸收胶原膜,6个月后活检进行组织形态计量和微型CT分析,CBCT评估牙槽嵴尺寸变化,植入种植体随访21个月。结果显示支架定制简便,无严重不良事件,1例因早期暴露移除,微型CT和组织学证实新骨形成,牙槽嵴宽度和高度变化极小,表明该支架安全有效,能促进骨再生并保存牙槽嵴体积。

要点

  • 二氧化钛支架在拔牙窝内放置安全,无严重不良事件。
  • 微型CT和组织学证实支架促进新骨形成。
  • 支架能有效保存牙槽嵴宽度和高度,体积变化极小。

核心结论

  • 二氧化钛支架是促进人牙槽骨骨再生和保存体积的安全有效选择,有助于拔牙后骨形成和维持牙槽嵴尺寸。

研究设计与样本

  • 可行性研究,纳入9名需拔除至少1颗前磨牙或磨牙的受试者,拔牙后放置多孔陶瓷二氧化钛支架并覆盖可吸收胶原膜,6个月后活检进行组织形态计量和微型CT分析,基线和6个月时CBCT评估牙槽嵴尺寸变化,植入种植体随访21个月。

主要发现

  • 支架椅旁调整简便,6个月随访期间无严重不良事件。
  • 1例支架因早期暴露被移除,其余9例支架成功整合。
  • 2个位点在1-2周出现轻微软组织裂开,自行愈合。
  • 微型CT和组织学证实新骨形成,软组织愈合良好,无不良反应。
  • 尺寸分析显示牙槽嵴宽度和高度变化极小,表明有效保存了体积。

临床怎么用

  • 对于需拔牙并计划种植的患者,可考虑使用二氧化钛支架进行牙槽嵴保存,以促进骨再生和维持牙槽嵴体积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study evaluates the safety and osteoconductive potential of a ceramic TiO2 scaffold in human alveolar bone, hypothesising that placement in human extraction sockets is safe, supports bone ingrowth and preserves ridge dimensions. MATERIAL AND METHODS: Nine subjects requiring the extraction of ≥ 1 premolar or molar tooth were enrolled. Full-thickness mucoperiosteal flaps were elevated. Following tooth extraction, porous ceramic TiO2 scaffolds were adjusted chair-side, placed into the extraction socket and covered by a resorbable collagen membrane. After 6 months of healing, before dental implant placement, a biopsy was performed at the site where the scaffold had been placed. Histomorphometric and micro-CT analyses were made. CBCT images were made at baseline and at 6 months to assess alveolar ridge dimensional changes. Implants placed in regenerated bone were followed for 21 months. RESULTS: Scaffold customisation with chairside adjustment was straightforward. No serious adverse events were observed during the 6 months following scaffold implantation. One scaffold was removed due to an early exposure, while the remaining 9 scaffolds successfully integrated. Two sites presented with minor soft tissue dehiscences at 1-2 weeks, which healed spontaneously. Micro-CT and histology confirmed new bone formation. Soft tissue healing was favourable, with no adverse reactions. Dimensional analysis revealed minimal changes in alveolar ridge width and height, indicating effective preservation of volume. CONCLUSIONS: This clinical study confirms that TiO2 scaffolds are a safe and effective option for promoting bone regrowth and preserving volume in human alveolar bone, thereby facilitating bone formation and maintaining ridge dimensions post-extraction. TRIAL REGISTRATION: This trial was registered at ClinicalTrials.gov (NCT06269497) on 1 December 2022.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Nysæther I, Haugen HJ, El Khassawna T, et al. Clinical Performance of Ultra-Porous TiO2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation-A Feasibility Study. Clin Oral Implants Res. 2025. PMID: 41320732. doi:10.1111/clr.70074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。